Sutro Biopharma Inc (STRO)
2.51
-0.02
(-0.79%)
USD |
NASDAQ |
Nov 22, 16:00
2.52
+0.01
(+0.40%)
After-Hours: 20:00
Sutro Biopharma Total Assets (Quarterly): 451.83M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 451.83M |
| June 30, 2024 | 489.04M |
| March 31, 2024 | 403.40M |
| December 31, 2023 | 470.74M |
| September 30, 2023 | 431.73M |
| June 30, 2023 | 464.90M |
| March 31, 2023 | 358.02M |
| December 31, 2022 | 406.94M |
| September 30, 2022 | 400.70M |
| June 30, 2022 | 385.62M |
| March 31, 2022 | 303.68M |
| December 31, 2021 | 341.41M |
| September 30, 2021 | 371.47M |
| June 30, 2021 | 359.79M |
| Date | Value |
|---|---|
| March 31, 2021 | 358.53M |
| December 31, 2020 | 394.11M |
| September 30, 2020 | 307.24M |
| June 30, 2020 | 277.54M |
| March 31, 2020 | 153.88M |
| December 31, 2019 | 156.37M |
| September 30, 2019 | 171.68M |
| June 30, 2019 | 188.81M |
| March 31, 2019 | 202.46M |
| December 31, 2018 | 223.14M |
| September 30, 2018 | 145.03M |
| June 30, 2018 | 45.18M |
| December 31, 2017 | 40.77M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
153.88M
Minimum
Mar 2020
489.04M
Maximum
Jun 2024
364.35M
Average
378.55M
Median
Total Assets (Quarterly) Benchmarks
| Fulcrum Therapeutics Inc | 279.01M |
| NovaBay Pharmaceuticals Inc | 3.877M |
| Palatin Technologies Inc | 3.415M |
| iBio Inc | 24.52M |
| Theriva Biologics Inc | 40.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 340.61M |
| Shareholders Equity (Quarterly) | 111.22M |
| Current Ratio | 3.091 |
| Net Debt Paydown Yield | 0.72% |